Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B

Why It Matters

The acquisition fast‑tracks Hims & Hers’ global expansion, adding a high‑growth telehealth platform and regulatory foothold in the Asia‑Pacific region, and intensifies consolidation in the digital health market.

Key Takeaways

• Deal valued up to $1.15 billion, $240 M cash upfront
• Eucalyptus ARR exceeds $450 M with 775k customers
• Triple‑digit ARR growth each quarter in 2025
• Expands Hims & Hers into Australia, Japan, Asia‑Pacific
• Tim Doyle becomes SVP of International at Hims & Hers

Pulse Analysis

Hims & Hers has been building a portfolio of consumer‑focused telehealth brands, but its growth has been constrained by geographic concentration. By acquiring Eucalyptus, the company taps into a market where digital health adoption is accelerating, driven by strong broadband penetration and a post‑pandemic shift toward remote care. The Australian market, valued at over $2 billion, offers a gateway to the broader Asia‑Pacific region, where regulatory frameworks are becoming more favorable for telemedicine providers.

Eucalyptus brings more than just a customer base; its house‑of‑brands model, featuring Juniper and Pilot, mirrors Hims & Hers’ aesthetic and subscription‑driven revenue engine. The firm’s $450 million ARR and near‑two‑million consultations demonstrate a scalable platform capable of delivering high‑margin services. Moreover, its accreditation by the Australian Council on Healthcare Standards provides a rare stamp of clinical credibility, positioning the combined entity as a trusted provider in a market where regulatory compliance remains a barrier to entry.

Financially, the deal’s structure protects Hims & Hers’ balance sheet, limiting immediate cash outlay while aligning earn‑out targets with performance milestones through 2029. This risk‑adjusted approach allows the company to leverage Eucalyptus’ growth trajectory without overleveraging. Strategically, the acquisition signals a broader industry trend toward consolidation, as players seek to achieve economies of scale, cross‑border synergies, and diversified revenue streams. If integration succeeds, Hims & Hers could emerge as a dominant global telehealth brand, challenging incumbents and attracting further investment in the sector.